Get it on Google Play

PopART: All-Out War On AIDS In Africa

PopART: All-Out War On AIDS In Africa

Author: Audio Medica December 17, 2011 Duration: 9:20
London School of Hygiene and Tropical Medicine Audio News - LSHTM Podcast
ScienceMedicineScience & Medicine
LONDON—A massive new study of HIV/AIDS could help turn the tide of the epidemic globally. The PopART study — of 24 communities in Zambia and South Africa — is testing a powerful combination of approaches to HIV in the community: universal testing, immediate treatment for patients and a range of preventive measures. The $37 million research trial is jointly funded by the Office of the US Global AIDS Coordinator, the National Institutes of Health, and the Bill & Melinda Gates Foundation. Professor Richard Hayes of the London School of Hygiene & Tropical Medicine described the rationale and the potential benefit of the PopART study to Derek Thorne.

Produced in collaboration with London School of Hygiene and Tropical Medicine Audio News-LSHTM Podcast, this series from Audio Medica delves into the complex and urgent world of global health. Rather than offering simple summaries, each episode unpacks the research and real-world implications behind critical policy decisions, from pandemic preparedness and vaccine equity to tackling non-communicable diseases and climate-related health threats. You'll hear directly from the School's researchers, field experts, and policy architects as they break down their findings and discuss the tangible impacts on communities worldwide. The conversations are grounded in the rigorous science for which LSHTM is renowned, yet presented with clarity for anyone invested in the future of public health. This podcast serves as an essential audio briefing for professionals, students, and engaged citizens who want to move beyond headlines and understand the evidence shaping our collective well-being. Tune in for thoughtful, authoritative discussions that connect academic excellence with the pressing health challenges of our time.
Author: Language: English Episodes: 50

Official website RSS
London School of Hygiene and Tropical Medicine Audio News - LSHTM Podcast
Podcast Episodes
Bed-Nets To Prevent Malaria: Latest Research Evidence [not-audio_url] [/not-audio_url]

Duration: 5:33
LONDON—The importance of continuing to use insecticide treated bed-nets in malaria-affected regions has been emphasised by a leading expert commenting on new research from Senegal (published in The Lancet Infectious Dise…
Low Cost Screening Could Halve Stillbirths Due To Syphilis [not-audio_url] [/not-audio_url]

Duration: 7:48
London School of Hygiene and Tropical Medicine Audio News: Low Cost Screening Could Halve Stillbirths Due To Syphilis LONDON—Scientists from London and Switzerland have reported in The Lancet medical journal that a simpl…
The New Decade Of Vaccines: Avoiding Public Distrust [not-audio_url] [/not-audio_url]

Duration: 2:51
London School of Hygiene and Tropical Medicine Audio News: The New Decade Of Vaccines: Avoiding Public Distrust “Public trust and public confidence in vaccines are vital to keeping immunisation rates up and keeping the v…
Txt2Stop: Text Messaging Doubled Smoking Quit Rates [not-audio_url] [/not-audio_url]

Duration: 4:42
Smokers were twice as likely to succeed when they tried to stop smoking if they received supportive text messages while they were trying — that was in a randomised controlled trial with 5 000 volunteer quitters undertake…
Vaccination and Global Health: USA Honours British Scientist [not-audio_url] [/not-audio_url]

Duration: 11:53
ATLANTA—Just before the successful Global Alliance on Vaccines and Immunisation (GAVI) talks took place in London a British scientist was honoured by the United States in Atlanta, Georgia. Professor Brian Greenwood gave…
GAVI Talks: New Funding Mechanisms Make Vaccines Affordable [not-audio_url] [/not-audio_url]

Duration: 4:00
LONDON—Part of the success of the Global Alliance for Vaccines and Immunisation (GAVI) talks held in London may have been the availability of new ways of funding vaccines to guarantee their affordability in low and middl…

«12345